EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE-STAGE CKD

被引：0
|
作者：
Hattanda, Fumihiko [1 ]
Makita, Minoru [1 ]
Takeda, Sayo [1 ]
Watanabe, Kanako [1 ]
Kawashima, Keisuke [1 ]
Kondo, Keiichi [1 ]
Ishikawa, Yozou [1 ]
Kusunoki, Yoshihiro [1 ]
Ishikawa, Yasunobu [1 ]
Nishio, Saori [1 ]
Atsumi, Tatsuya [1 ]
机构：
[1] Hokkaido Univ, Dept Med 2, Sapporo, Hokkaido, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP013
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE STAGE CKD
    Hattanda, Fumihiko
    Nishio, Saori
    Takeda, Sayo
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [2] EFFICACY AND SAFETY OF TOLVAPTAN ON ADPKD PATIENTS IN LATE-STAGE CKD
    Hattanda, Fumihiko
    Makita, Minoru
    Kawashima, Keisuke
    Kondo, Keiichi
    Kusunoki, Yoshihiro
    Matsuoka, Naoko
    Yamamoto, Junya
    Nakagaki, Tasuku
    Nishio, Saori
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 92 - 92
  • [3] Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
    Gittus, Matt
    Haley, Helen
    Harris, Tess
    Borrows, Sarah
    Padmanabhan, Neal
    Gale, Danny
    Simms, Roslyn
    Williams, Terri
    Acquaye, Aaron
    Wong, Alisa
    Chan, Melanie
    Lee, Eduardo
    Ong, Albert C. M.
    BMC NEPHROLOGY, 2025, 26 (01)
  • [4] THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Muto, Satoru
    Kawano, Haruna
    Sugiura, Syou-ichiro
    Kitamura, Kousuke
    Kimura, Masaki
    Isotani, Shuji
    Ide, Hisamitsu
    Yamaguchi, Raizo
    Horie, Shigeo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [5] A PROSPECTIVE STUDY OF THE EFFICACY AND ADVERSE EFFECTS OF TOLVAPTAN FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Kai, Hirayasu
    Tsunoda, Ryoya
    Kawamura, Tetsuya
    Fujita, Akiko
    Kaneko, Shuzo
    Morito, Naoki
    Usui, Joichi
    Saito, Chie
    Nakamura, Taichi
    Yamagata, Kunihiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 68 - 68
  • [6] A POST-HOC ANALYSIS OF EFFICACY AND SAFETY OF TOLVAPTAN (TOL) IN DECREASING RATE OF RENAL FUNCTION DECLINE IN PATIENTS WITH VERY LATE-STAGE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Torres, Vicente
    Gansevoort, Ronald
    Perrone, Ron
    Chapman, Arlene
    Ouyang, John
    Lee, Jennifer
    Japes, Hina
    Wang, Tao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1001 - 1001
  • [7] EVALUATION OF THE EFFECT OF TOLVAPTAN ON OXIDATIVE STRESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Rigato, Matteo
    Bertoldi, Giovanni
    Ravarotto, Verdiana
    Carraro, Gianni
    Calo, Lorenzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [8] Single center experience with tolvaptan in nine patients with autosomal dominant polycystic kidney disease (ADPKD)
    Hess, Nina
    Pollock, Emily
    Scharer, Verena
    Kobel, Claudia
    Weber, Nina
    Ritter, Alexander
    Mueller, Thomas
    Wuthrich, Rudolf P.
    Lorenzen, Johan
    SWISS MEDICAL WEEKLY, 2017, 147 : 13S - 13S
  • [9] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [10] CLINICAL EFFICACY OF TREATMENT WITH TOLVAPTAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Martins Munoz, Judith
    Tarragon, Blanca
    De Lorenzo, Alberto
    Espinel, Laura
    Teresa Naya, Maria
    Cubas, Alfonso
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I13 - I13
12345